咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Targeting the RAS/RAF/MAPK pat... 收藏

Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies

作     者:Md Entaz Bahar Hyun Joon Kim Deok Ryong Kim Entaz Bahar;Hyun Joon Kim;Deok Ryong Kim

作者机构:Department of Biochemistry and Convergence Medical Sciences and Institute of Medical ScienceGyeongsang National UniversityCollege of MedicineJinjuSouth Korea Department of Anatomy and Convergence Medical Sciences and Institute of Medical ScienceGyeongsang National UniversityCollege of MedicineJinjuSouth Korea 

出 版 物:《Signal Transduction and Targeted Therapy》 (信号转导与靶向治疗(英文))

年 卷 期:2024年第9卷第1期

页      面:173-210页

核心收录:

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基  金:supported by grants from the Basic Science Research Program through the National Research Foundation of Korea(RS-2023-00219399,RS-2023-00238051) by the Commercializations Promotion Agency for R&D Outcomes(COMPA)grant funded by the Korea government(MSIT)(1711173796) 

主  题:RAF insight mechanism 

摘      要:Metastatic dissemination of solid tumors,a leading cause of cancer-related mortality,underscores the urgent need for enhanced insights into the molecular and cellular mechanisms underlying metastasis,chemoresistance,and the mechanistic backgrounds of individuals whose cancers are prone to *** most prevalent signaling cascade governed by multi-kinase inhibitors is the mitogen-activated protein kinase(MAPK)pathway,encompassing the RAS–RAF–MAPK kinase(MEK)–extracellular signal-related kinase(ERK)*** kinase is a primary mediator of the MAPK pathway,responsible for the sequential activation of downstream targets,such as MEK and the transcription factor ERK,which control numerous cellular and physiological processes,including organism development,cell cycle control,cell proliferation and differentiation,cell survival,and *** in this signaling cascade are associated with diseases such as *** inhibitors(RAFi)combined with MEK blockers represent an FDAapproved therapeutic strategy for numerous RAF-mutant cancers,including melanoma,non-small cell lung carcinoma,and thyroid ***,the development of therapy resistance by cancer cells remains an important ***,an intracellular lysosome-dependent catabolic recycling process,plays a critical role in the development of RAFi resistance in ***,targeting RAF and autophagy could be novel treatment strategies for RAF-mutant *** this review,we delve deeper into the mechanistic insights surrounding RAF kinase signaling in tumorigenesis and ***,we explore and discuss the ongoing development of next-generation RAF inhibitors with enhanced therapeutic ***,this review sheds light on the functional interplay between RAF-targeted therapies and autophagy in cancer.

读者评论 与其他读者分享你的观点